Tecan Group Announces Conference Call for H1 2025 Results
Tecan Group's Upcoming Conference Call
Tecan Group AG is all set to hold an important conference call to discuss its financial performance for the first half of 2025. This conference is scheduled for a Tuesday at 08:30 CEST. Financial results will be available to the public a few hours earlier, at 6:00 CEST on the same day.
How to Access the Conference Call
The conference call will be accessible as an audio-webcast, featuring synchronized presentation slides for enhanced understanding. Interested parties who wish to participate can also access the event via telephone. This flexibility facilitates broader engagement, allowing both local and international participants to join in.
Dial-in Instructions
The following dial-in numbers will be available for participants:
For European Participants: +41 (0) 58 310 50 00 or +44 (0) 207 107 0613 (UK)
For Participants from the U.S.: +1 (1) 631 570 56 13
To ensure smooth participation, attendees are encouraged to connect at least 15 minutes prior to the official start time.
Accessing Financial Reports
On the same date as the conference call, Tecan will also publish its full 2025 Interim Report, readily accessible in the 'Investor Relations' section on their website. This report will provide comprehensive insights into the company’s financial health, operations, and strategies moving forward.
About Tecan Group AG
Tecan has established itself as a leader in the life sciences sector, specializing in laboratory automation and healthcare innovation. Founded in Switzerland in 1980, Tecan strives to enhance health outcomes by equipping customers with advanced tools for innovation. The company employs over 3,000 individuals and has expanded its operational footprint across Europe, North America, and Asia, ensuring a robust service network in over 70 countries.
In 2024, Tecan achieved impressive sales figures amounting to CHF 934 million, equivalent to USD 1,062 million and EUR 984 million. Their commitment to quality and innovation is reflected in their vast range of OEM instruments, components, and medical devices, all of which are produced with the highest standards of excellence. Registered shares of Tecan Group (SIX Swiss Exchange: TECN) are actively traded, showcasing their strong market presence.
Contacting Tecan Group
For further inquiries or information, Tecan Group can be reached through:
Martin Braendle
Senior Vice President, Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
Email: investor@tecan.com
Website: www.tecan.com
Frequently Asked Questions
When is the Tecan Group conference call scheduled?
The conference call is scheduled for August 12th, 2025, at 08:30 CEST.
How can I join the Tecan conference call?
You can join via audio-webcast or by phone using appropriate dial-in numbers based on your location.
Where will the financial results be published?
The financial results will be published on Tecan's website in the 'Investor Relations' section on the same day of the conference call.
What does Tecan Group specialize in?
Tecan specializes in laboratory automation and healthcare innovation, helping to improve health outcomes globally.
What were Tecan's sales figures in 2024?
In 2024, Tecan reported sales of CHF 934 million, equivalent to approximately USD 1,062 million.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.